Key result
In dogs with myxomatous mitral valve disease, left atrial maximal volume > 3.53 mL/kg was independently associated with an increased risk of cardiac-related death.
Why the study?
Do left atrial morphological and functional echocardiographic indices predict cardiac-related death in dogs with myxomatous mitral valve disease?
Cohort (n=115)
No
Do left atrial morphological and functional echocardiographic indices predict cardiac-related death in dogs with myxomatous mitral valve disease?
Left atrial maximal volume (LAVmax) is a stronger volumetric predictor of cardiac death in dogs with MMVD than standard linear measurements or speckle-tracking derived variables.
Answers are grounded in this paper and cite their sources.
LAVmax may refine MMVD prognosis beyond linear indices; leaves open whether volumetric measures alter management or outcomes.
BACKGROUND: The prognostic relevance of left atrial (LA) morphological and functional variables, including those derived from speckle tracking echocardiography (STE), has been little investigated in veterinary medicine. OBJECTIVES: To assess the prognostic value of several echocardiographic variables, with a focus on LA morphological and functional variables in dogs with myxomatous mitral valve disease (MMVD). ANIMALS: One-hundred and fifteen dogs of different breeds with MMVD. METHODS: Prospective cohort study. Conventional morphologic and echo-Doppler variables, LA areas and volumes, and STE-based LA strain analysis were performed in all dogs. A survival analysis was performed to test for the best echocardiographic predictors of cardiac-related death. RESULTS: Most of the tested variables, including all LA STE-derived variables were univariate predictors of cardiac death in Cox proportional hazard analysis. Because of strong correlation between many variables, only left atrium to aorta ratio (LA/Ao > 1.7), mitral valve E wave velocity (MV E vel > 1.3 m/s), LA maximal volume (LAVmax > 3.53 mL/kg), peak atrial longitudinal strain (PALS < 30%), and contraction strain index (CSI per 1% increase) were entered in the univariate analysis, and all were predictors of cardiac death. However, only the MV E vel (hazard ratio [HR], 4.45; confidence interval [CI], 1.76-11.24; P < .001) and LAVmax (HR, 2.32; CI, 1.10-4.89; P = .024) remained statistically significant in the multivariable analysis. CONCLUSIONS AND CLINICAL IMPORTANCE: The assessment of LA dimension and function provides useful prognostic information in dogs with MMVD. Considering all the LA variables, LAVmax appears the strongest predictor of cardiac death, being superior to LA/Ao and STE-derived variables.
No takes yet. Share an insight, caveat, or question.
Toaldo et al. (2018) conducted a cohort in Myxomatous mitral valve disease (MMVD) (n=115). Left atrial maximal volume (LAVmax) > 3.53 mL/kg vs. LAVmax ≤ 3.53 mL/kg was evaluated on Cardiac-related death (HR 2.32, 95% CI 1.10-4.89, p=0.024). In dogs with myxomatous mitral valve disease, left atrial maximal volume > 3.53 mL/kg was independently associated with an increased risk of cardiac-related death.
Synapse has enriched 10 related papers. Consider them for comparative context: